Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease
/in International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2017-06-01 / Clin Adv Hematol Oncol 2017 Jun;15(6):466-477Current status of clinical trials assessing oncolytic virus therapy for urological cancers
/in Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial Carcinoma /von 2017-03-21 / Int. J. Urol. 2017 05;24(5):342-351Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-12-01 / Urol Oncol 2016 12;34(12):538-547Immunotherapy for the Treatment of Urothelial Carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-07-25 / J Urol 2017 01;197(1):14-22Recent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial Carcinoma /von 2016-06-03 / BJU Int. 2016 10;118(4):506-14Novel immunotherapeutic approaches to the treatment of urothelial carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-14Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2012-08-09 / Int. Immunopharmacol. 2012 Nov;14(3):252-60The immunotherapy of prostate and bladder cancer
/in International Publications, Urothelial Carcinoma /von 2005-10-01 / BJU Int. 2005 Oct;96(5):728-35[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2005-01-01 / Vopr Onkol 2005;51(6):685-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de